MedPath

Diabetes Medical Nutrition Therapy in Southeastern African American Women

Not Applicable
Recruiting
Conditions
Type 2 Diabetes
Interventions
Behavioral: Diabetes MNT
Behavioral: Motivational Interviewing
Registration Number
NCT04971889
Lead Sponsor
Meharry Medical College
Brief Summary

A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
291
Inclusion Criteria
  • African American
  • Female
  • Clinical diagnosis of type 2 diabetes for at least 6 months
  • At risk for development and/or progression of diabetes complications (HbA1c ≥ 7.0% AND either systolic blood pressure ≥130, LDL cholesterol ≥ 100, or BMI ≥ 30).
Exclusion Criteria

--Observed or diagnosed psychotic disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diabetes MNT plus MIMotivational Interviewing--Group-based dietary/dietary motivation intervention
Diabetes MNT plus MIDiabetes MNT--Group-based dietary/dietary motivation intervention
Diabetes MNTDiabetes MNT-Group-based dietary intervention
Primary Outcome Measures
NameTimeMethod
HbA1cBaseline

Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Change from Baseline HbA1c12 months

Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Secondary Outcome Measures
NameTimeMethod
LDL CholesterolBaseline

Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.

Systolic Blood PressureBaseline

A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.

Body Mass IndexBaseline

Calculated measure of body max index from height/weight measures

Change from baseline LDL Cholesterol12 months

Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.

Change from Baseline Body Mass Index12 months

Calculated measure of body max index from height/weight measures

Change from baseline Systolic Blood Pressure12 months

A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.

Trial Locations

Locations (2)

Meharry Medical College

🇺🇸

Nashville, Tennessee, United States

Matthew Walker Comprehensive Health Center

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath